Research Article
Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway
Figure 4
The expression of SIRT1, p-AMPKα/total AMPKα, and HNF4A in mice renal tissue treated with GDC, valsartan, and baicalin. (a and b) The levels of SIRT1, p-AMPKα, T-AMPKα, and HNF4A in mice renal tissue treated with GDC were analyzed by western blot. (c and d) The levels of SIRT1, p-AMPKα, T-AMPKα, and HNF4A in mice renal tissue treated with baicalin were analyzed by western blot. (e–g) Quantitative analyses of western blot by GDC treatment: SIRT1/β-actin; p-AMPKα/total AMPKα; and HNF4A/β-actin. (h–j) Quantitative analyses of western blot by baicalin treatment: SIRT1/β-actin; p-AMPKα/total AMPKα; and HNF4A/β-actin. , , and .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |
(j) |